Pharmacy -- Law and legislation -- United States

See also what's at your library, or elsewhere.

• Pharmacy -- Law and legislation
• Pharmacy -- United States

• Pharmacy -- Law and legislation -- United States -- Handbooks, manuals, etc.
• Pharmacy -- Law and legislation -- Alabama
• Pharmacy -- Law and legislation -- Iowa
• Pharmacy -- Law and legislation -- Maryland
• Pharmacy -- Law and legislation -- Michigan
• Pharmacy -- Law and legislation -- Pennsylvania

• Substitute prescription drug act hearings before the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, on H.R. 1963 ... June 22 and July 27, 1978. (Washington : U.S. Govt. Print. Off., 1978), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Consumer Protection and Finance (page images at HathiTrust)
• A manual on pharmaceutical law, together with appendices containing important laws of Congresses, (Philadelphia, Lea & Febiger, 1938), by Charles Leonard O'Connell (page images at HathiTrust)
• FDA user fees : current measures not sufficient for evaluating effect on public health : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives / United States General Accounting Office. (Washington, D.C. : The Office, [1994]), by United States General Accounting Office (page images at HathiTrust)
• Pharmacy law; a treatise defining the rights, duties, obligations and liabilities of druggists, by Lawrence De Graff. (Des Moines, Ia. (Richards & Cassel, printers), 1916), by Lawrence De Graff (page images at HathiTrust)
• NASPER : why has the National All Schedules Prescription Electronic Reporting Act not been implemented? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, October 24, 2007. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
• The Food and Drug Import Safety Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, on H.R. 3610, September 26, 2007. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
• Pharmacy robbery legislation hearing before the Subcommittee on Criminal Law of the Committee on the Judiciary, United States Senate, Ninety-seventh Congress, second session, on S. 20, S. 661, S. 954, S. 1025, S. 1339, and H.R. 2034 ... June 17, 1982. (Washington : U.S. G.P.O., 1982), by United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Criminal Law (page images at HathiTrust)
• Examination of the pharmaceutical industry, 1973-74 hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, first and second sessions, on S. 3441 and S. 966 .... (Washington : U.S. Govt. Print. Off., 1973 [i.e. 1974]-), by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health (page images at HathiTrust)
• National All Schedules Prescription Electronic Reporting Act of 2004 : report (to accompany H.R. 3015) (including cost estimate of the Congressional Budget Office). ([Washington, D.C. : U.S. G.P.O., 2004]), by United States. Congress. House. Committee on Commerce. Subcommittee on Energy and Power (page images at HathiTrust)
• National All Schedules Prescription Electronic Reporting Act of 2005 : report (to accompany H.R. 1132) (including cost estimate of the Congressional Budget Office). ([Washington, D.C. : U.S. G.P.O., 2005]), by United States. Congress. House. Committee on Energy and Commerce (page images at HathiTrust)
• National All Schedules Prescription Electronic Reporting Act of 2005 : report (to accompany S. 518). ([Washington, D.C. : U.S. G.P.O., 2005]), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., 1987), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
• Food, drug, and cosmetic act amendments of 1977 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, first session, on S. 1831 ... July 26 and 27, 1977. (Washington : U.S. Govt. Print. Off. : [For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office], 1978), by United State Senate Subcommittee on Health and Scientific Research (page images at HathiTrust)
• The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982. (Washington : U.S. G.P.O. : [For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office], 1982), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
• A prescription for safety : the need for H.R. 3880, the Internet Pharmacy Consumer Protection Act : hearing before the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, second session, March 18, 2004. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004), by United State House Committee on Government Reform (page images at HathiTrust)
• Pharmacy robbery legislation : hearing before the Subcommittee on Criminal Law of the Committee on the Judiciary, United States Senate, Ninety-seventh Congress, second session, on S. 20, S. 661, S. 954, S. 1025, S. 1339, and H.R. 2034 ... June 17, 1982. (Washington : U.S. G.P.O. : [For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office], 1982), by United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Criminal Law (page images at HathiTrust)
• Drug regulation reform act of 1979 hearings before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session, on S. 1075 ... May 17 and 18, 1979. (Washington : U.S. Govt. Print. Off., 1979), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research (page images at HathiTrust)
• A treatise on pharmacal jurisprudence : with a thesis on the law in general / by Harley R. Wiley. (San Francisco : Hicks-Judd Company, 1904), by Harley R. Wiley (page images at HathiTrust)
• Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1991), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)

• A security outline of the Controlled Substances Act of 1970 / Robert C. Bonner, Gene R. Haislip. ([Washington, D.C.?] : U.S. Dept. of Justice, Drug Enforcement Administration, 1991 [i.e. 1993]), by Robert C. Bonner (page images at HathiTrust)

• Proceedings of the annual convention of the Alabama Pharmaceutical Association. ([s.1.], [s.n.]), by Alabama Pharmaceutical Association (page images at HathiTrust)

• Pharmacy law, including rules and regulations, and amendments of the thirty-seventh General assembly. (Des Moines : Pub. by the state of Iowa, [1917]), by Iowa (page images at HathiTrust)

• Annual report of the Maryland Board of Pharmacy. (Baltimore, Md. : The Board.), by Maryland Board of Pharmacy (page images at HathiTrust)

• Pharmacy and drug laws ([Lansing?]), by Michigan (page images at HathiTrust)

• A manual on pharmaceutical law, together with appendices containing important laws of Congresses, (Philadelphia, Lea & Febiger, 1938), by Charles Leonard O'Connell (page images at HathiTrust)

Items below (if any) are from related and broader terms.

• Pharmacist's manual : an informational outline of the Controlled substances act of 1970. (Washington : Drug Enforcement Administration, U.S. Dept. of Justice, 1978), by United States. Drug Enforcement Administration. Office of Compliance and Regulatory Affairs (page images at HathiTrust)
• Pharmacist's manual : an informational outline of the Controlled Substances Act of 1970 / [prepared by the Office of Diversion Control]. (Washington, D.C. : U.S. Dept. of Justice, Drug Enforcement Administration, 1986) (page images at HathiTrust)
• Pharmaceutical jurisprudence. (New York [Columbia University Book Store], 1952), by Sol A. Herzog (page images at HathiTrust)
• Position of pharmacy in sickness insurance, by George Urdang ... and Jennings Murphy ... ([Madison, Wis., American institute of the history of pharmacy, 1942]), by George Urdang (page images at HathiTrust)

• Manuel légal des pharmaciens et des élèves en pharmacie, ou, Recueil des lois arrêtés, reglèments et instructions concernant l'enseignement, les études et l'exercice de la pharmacie, et comprenant le programme des cours de l'Ecole de pharmacie de Paris / par N.J.-B.G. Guibourt. (Paris : Baillière, 1852), by N.-J.-B.-G. Guibourt (page images at HathiTrust)

• Entwurf und Vorschlag zu einer Apotheker-Ordnung und zur Regulirung einiger damit unmittelbar zusammanhängender Theile der medicinalgeordneter Staaten, von Martin Balduin Kittel. (Nürnberg, Bei J.L. Schrag, 1830), by Martin Baldwin Kittel (page images at HathiTrust)
• Beleuchtung der Verhältnisse der Teutschen Apotheken zum Staatte, zur Gesetzgebung und zum Arzte : gelegentlich des Entwurfs einer neuen Medicinalordnung für Baden, unter Mitwirkung des Ausschusses des badischen Apothekervereins, im Auftrage der Plenarversammlung des Vereins / verfasst von I.M.A. Probst. (Heidelberg : J.C.B. Mohr, 1841), by I. M. A. Probst (page images at HathiTrust)

• A statement by the Society of Apothecaries, on the subject of their administration of the Apothecaries' Act : with reference to some supposed feature of Sir James Graham's promised measure of medical reform. (London : Gilbert & Rivington, 1844), by London Society of Apothecaries (page images at HathiTrust)

• Concordia y Reales Ordenanzas para el régimen y gobierno de la Facultad de Farmacia : formadas con conocimiento de la Real Junta General de Gobierno de la Facultad reunida, en que se declara la autoridad de la Junta Superior Gubernativa de la expresada de Farmacia en todos los dominios de S.M., el método de estudios que han de seguir los que se dediquen á esta ciencia y los grados y prerogativas que se les conceden. (Reimpresa en Valencia : en la Oficina de D. Benito Monfort, 1800) (page images at HathiTrust)

• Manuel légal des pharmaciens et des élèves en pharmacie, ou, Recueil des lois arrêtés, reglèments et instructions concernant l'enseignement, les études et l'exercice de la pharmacie, et comprenant le programme des cours de l'Ecole de pharmacie de Paris / par N.J.-B.G. Guibourt. (Paris : Baillière, 1852), by N.-J.-B.-G. Guibourt (page images at HathiTrust)

• Year book of the American Pharmaceutical Association. (Baltimore, Md. [etc.] The American Pharmaceutical Association.), by American Pharmaceutical Association (page images at HathiTrust)
• Pharmacist's manual : an informational outline of the Controlled substances act of 1970. (Washington : Drug Enforcement Administration, U.S. Dept. of Justice, 1978), by United States. Drug Enforcement Administration. Office of Compliance and Regulatory Affairs (page images at HathiTrust)
• Pharmacist's manual : an informational outline of the Controlled Substances Act of 1970 / [prepared by the Office of Diversion Control]. (Washington, D.C. : U.S. Dept. of Justice, Drug Enforcement Administration, 1986) (page images at HathiTrust)
• Stubbs buyers directory for the wholesale drug, chemical, and allied trades : listing anilines, chemicals, dyestuffs, drugs, gums, oils, essential oils, crude and raw materials for textile mills, dyers, perfumers, paper mills, bleachers, confectioners and for the manufacturers of rubber, glass, soaps, toilet preparations, pharmaceuticals, patent medicines, etc. (New York : A. Stubbs, c1918) (page images at HathiTrust)
• The professional pharmacy; an analysis of prescription department activities; part of the national drug store survey. ([Washington] American Pharmaceutical Assn., 1935), by Frank Anthony Delgado (page images at HathiTrust)
• The Dixie druggist (Hickory, N. C., n.p.) (page images at HathiTrust)

• Drug Supplies in the American Revolution (reprint from a 1961 bulletin), by George B. Griffenhagen (Gutenberg text and illustrated HTML)

• Quick index to general subjects of interest related to drug regulation. (Rockville, MD : U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, [1992-) (page images at HathiTrust)

• The American new dispensatory : containing general principles of pharmaceutic chemistry, pharmaceutic operations, chemical analysis of the articles of materia medica, materia medica, including several new and valuable articles, the production of the United States, preparations and compositions ... / by James Thacher. (Boston, Mass. : T. B. Wait, 1810), by James Thacher (page images at HathiTrust)
• The dispensatory of the United States of America / by George B. Wood... and Franklin Bache... (Philadelphia : Lippincott, 1858), by George B. Wood (page images at HathiTrust)

• Food and Drug Administration's Critical Path Initiative : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Tenth Congress, first session, special hearing, June 1, 2007, Salt Lake City, Utah. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008), by Rural Development United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture (page images at HathiTrust)
• Oversight of the drug development program of the National Cancer Institute, 1982 : hearing before the Subcommittee on Investigations and General Oversight of the Committee on Labor and Human Resources, United States Senate, Ninety-seventh Congress, second session on examination of effective alternatives toward correcting deficiencies in the use of experimental drugs on cancer patients, March 5, 1982. (Washington : U.S. G.P.O. : [For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office], 1982), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Investigations and General Oversight (page images at HathiTrust)

• Adverse drug events : the magnitude of health risk is uncertain because of limited incidence data : report to Congressional requesters / United States General Accounting Office. (Washington, D.C. (P.O. Box 37050, Washington, D.C. 20013) : The Office, [2000]), by United States General Accounting Office (page images at HathiTrust)
• Board and care homes : elderly at risk from mishandled medications : report to the Chairman, Subcommittee on Health and Long-Term Care, Select Committee on Aging, House of Representatives / United States General Accounting Office. (Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20877) : The Office [distributor, 1992]), by United States General Accounting Office (page images at HathiTrust)

• Prices, Markets, and the Pharmaceutical Revolution (Washington: AEI Press, 2000), by John E. Calfee (PDF at AEI)
• Update of federal activities regarding the use of pneumococcal vaccine. (Washington, D.C. : Congress of the United States, Office of Technology Assessment : For sale by the Supt. of Docs., U.S. G.P.O., [1984]) (page images at HathiTrust)
• From test tube to patient : new drug development in the United States. ([Rockville, MD] : Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, [1995]) (page images at HathiTrust)
• The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1993. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993), by United States. Congress. Senate. Special Committee on Aging (page images at HathiTrust)
• The Food and Drug Administration's process for approving new drugs oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979. (Washington : U.S. Govt. Print. Off., 1979), by Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Science (page images at HathiTrust)
• Drug regulation reform--oversight hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session .... (Washington : U.S. G.P.O., 1980-), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
• FDA review and approval times : statement of Mary R. Hamilton, Director of Program Evaluation in the Human Services Area, Program Evaluation and Methodology Division, before the Committee on Labor and Human Resources, U.S. Senate / United States General Accounting Office. (Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1996]), by United States General Accounting Office (page images at HathiTrust)
• The Food and Drug Administration's process for approving new drugs report / prepared by the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, second session. (Washington : U.S. G.P.O., 1980), by Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Science (page images at HathiTrust)
• From test tube to patient : new drug development in the United States. (Rockville, MD : Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1990) (page images at HathiTrust)
• CDER ... report to the nation / Center for Drug Evaluation and Research. (Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 1998-), by Center for Drug Evaluation and Research (U.S.) (page images at HathiTrust)
• Uncertain returns : the multimillion dollar market in reimported pharmaceuticals : a staff report / prepared for the use of the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, U.S. House of Representatives. (Washington : U.S. G.P.O. :, 1986) (page images at HathiTrust)
• The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
• Pharmaceutical innovation--promises and problems hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment and the Subcommittee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, April 27, 1981. (Washington : U.S. G.P.O., 1982), by Agriculture Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Natural Resources (page images at HathiTrust)
• Drug lag hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981. (Washington : U.S. G.P.O., 1983), by Agriculture Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Natural Resources (page images at HathiTrust)
• Pill mills, Medicaid fraud, and the diversion of pharmaceuticals : hearing before the Select Committee on Narcotics Abuse and Control, House of Representatives, One Hundred Second Congress, second session, July 29, 1992. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992), by United States. Congress. House. Select Committee on Narcotics Abuse and Control (page images at HathiTrust)
• RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1994), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• Advisory Committee on the Food and Drug Administration : final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
• The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• Oxycontin and beyond : examining the role of FDA and DEA in regulating prescription painkillers : hearing before the Subcommittee on Regulatory Affairs of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, September 13, 2005. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005), by United States. Congress. House. Committee on Government Reform. Subcommittee on Regulatory Affairs (page images at HathiTrust)
• Prescription drug abuse : what is being done to address this new drug epidemic? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, July 26, 2006. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007), by Drug Policy United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice (page images at HathiTrust)
• Examining the implications of drug importation : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, July 14, 2004. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008), by United States Senate Committee on the Judiciary (page images at HathiTrust)
• The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1992. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993), by United States. Congress. Senate. Special Committee on Aging (page images at HathiTrust)
• Pharmacist's manual : an informational outline of the Controlled Substances Act of 1970 / [prepared by the Drug Enforcement Administration's Office of Diversion Control]. (Washington, D.C. : U.S. Dept. of Justice, Drug Enforcement Administration, 2001) (page images at HathiTrust)
• The war on drugs meets the war on pain : nursing home patients caught in the crossfire : listening session before the Special Committee on Aging, United States Senate, One Hundred Eleventh Congress, second session, Washington, DC, March 24, 2010. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2010), by United States. Congress. Senate. Special Committee on Aging (page images at HathiTrust)
• What is the U.S. role in combating the global HIV/AIDS epidemic? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, July 22, 1999. (Washington : U.S. G.P.O. : [U.S. G.P.O., Supt. of Docs., Congressional Sales Office, distributor], 2000), by Drug Policy United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice (page images at HathiTrust)
• Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
• Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004), by United States Senate Committee on the Judiciary (page images at HathiTrust)
• Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Drug importation : the realities of safety and security : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the realities of safety and security regarding drug importation, February 16, 2005. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Oversight hearing on the availability and eligibility for pharmaceutical services provided by the Department of Veterans Affairs : hearing before the Subcommittee on Health of the Committee on Veterans' Affairs, House of Representatives, One Hundred Eight [sic] Congress, first session, March 19, 2003. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004), by United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Health (page images at HathiTrust)
• Department of Veterans Affairs pharmaceutical procurement polcy : hearing before the Subcommittee on Health of the Committee on Veterans' Affairs, House of Representatives, One Hundred Sixth Congress, second session, July 25, 2000. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 2001), by United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Health (page images at HathiTrust)
• Department of Veterans Affairs pharmacy program with emphasis on OTC drugs, medical supplies, and dietary supplements : hearing before the Subcommittee on Hospitals and Health Care of the Committee on Veterans' Affairs, House of Representatives, One Hundred Fourth Congress, second session, June 11, 1996. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996), by United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Hospitals and Health Care (page images at HathiTrust)
• Assuring pharmacy services : principles and guidelines for the delivery of mandated pharmacy services in BCHS primary care projects. (Rockville, Md. : U.S. Dept. of Health, Education, and Welfare, Public Health Service, Health Services Administration, Bureau of Community Health Services (5600 Fishers Lane), [1980]), by United States. Health Services Administration. Bureau of Community Health Services (page images at HathiTrust)
• Report of the National Commission on Orphan Diseases. ([Rockville, MD] : U.S. Dept. of Health & Human Sevices, Public Health Service, Office of the Assistant Secretary for Health, [1989]), by National Commission on Orphan Diseases (U.S.) (page images at HathiTrust)
• Report to industry. (Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 1997), by Center for Drug Evaluation and Research (U.S.) (page images at HathiTrust)
• Final report / Review Panel on New Drug Regulation. ([Washington] : Dept. of Health, Education, and Welfare, 1977), by Education United States. Department of Health (page images at HathiTrust)

More items available under broader and related terms at left.